Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia

被引:252
作者
Kaidi, Abderrahmane [1 ]
Qualtrough, David [1 ]
Williams, Ann C. [1 ]
Paraskeva, Christos [1 ]
机构
[1] Univ Bristol, Fac Med & Vet Sci, Dept Cellular & Mol Med, Canc Res UK,Colorectal Tumor Biol Res Grp, Bristol BS8 1TD, Avon, England
关键词
D O I
10.1158/0008-5472.CAN-06-0425
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclooxygenase (COX)-2, the inducible key enzyme for prostanoid biosynthesis, is overexpressed in most colorectal carcinomas and a subset of colorectal adenomas. Genetic, biochemical, and clinical evidence indicates an important role for COX-2 in colorectal tumorigenesis. Although COX-2 can be induced by aberrant growth factor signaling and oncogene activation during colorectal tumorigenesis, the role of micro-environmental factors such as hypoxia in COX-2 regulation remains to be elucidated. For the first time, we report that under hypoxic conditions COX-2 protein levels increase in colorectal adenoma and carcinoma cells. Rigorous analyses reveal that COX-2 up-regulation is transcriptional and is associated with hypoxia-inducible factor (HIF)-1 alpha. induction. Oligonucleotide pull-down and chromatin immunoprecipitation assays reveal that HIF-1 alpha binds a hypoxia-responsive element on the COX-2 promoter. COX-2 up-regulation during hypoxia is accompanied by increased levels of prostaglandin E-2 (PGE(2)), which promote tumor cell survival under hypoxic conditions. In addition, elevated levels of PGE(2) in hypoxic colorectal tumor cells enhance vascular endothelial growth factor expression and HIF-1 transcriptional activity by activating the mitogen-activated protein kinase pathway, showing a potential positive feedback loop that contributes to COX-2 up-regulation during hypoxia. This study identifies COX-2 as a direct target for HIF-1 in colorectal tumor cells. In addition, COX-2 up-regulation represents a pivotal cellular adaptive response to hypoxia with implication for colorectal tumor cell survival and angiogenesis. We propose that using modified COX-2-selective inhibitors, which are only activated under hypoxic conditions, could potentially be a novel more selective strategy for colorectal cancer prevention and treatment.
引用
收藏
页码:6683 / 6691
页数:9
相关论文
共 51 条
[1]  
Araki Y, 2003, CANCER RES, V63, P728
[2]   An essential role for p300/CBP in the cellular response to hypoxia [J].
Arany, Z ;
Huang, LE ;
Eckner, R ;
Bhattacharya, S ;
Jiang, C ;
Goldberg, MA ;
Bunn, HF ;
Livingston, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :12969-12973
[3]   Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium [J].
Bonazzi, A ;
Mastyugin, V ;
Mieyal, PA ;
Dunn, MW ;
Laniado-Schwartzman, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2837-2844
[4]   COX-2: A molecular target for colorectal cancer prevention [J].
Brown, JR ;
DuBois, RN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2840-2855
[5]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[6]   Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression [J].
Chang, SH ;
Liu, CH ;
Conway, R ;
Han, DK ;
Nithipatikom, K ;
Trifan, OC ;
Lane, TF ;
Hla, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :591-596
[7]   Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence [J].
Chell, SD ;
Witherden, AR ;
Dobson, RR ;
Moorghen, M ;
Herman, AA ;
Qualtrough, D ;
Williams, AC ;
Paraskeva, C .
CANCER RESEARCH, 2006, 66 (06) :3106-3113
[8]   A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammmatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate [J].
Crew, TE ;
Elder, DJE ;
Paraskeva, C .
CARCINOGENESIS, 2000, 21 (01) :69-77
[9]   Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1α in non-small cell lung cancer [J].
Csiki, I ;
Yanagisawa, K ;
Haruki, N ;
Nadaf, S ;
Morrow, JD ;
Johnson, DH ;
Carbone, DP .
CANCER RESEARCH, 2006, 66 (01) :143-150
[10]   UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS [J].
EBERHART, CE ;
COFFEY, RJ ;
RADHIKA, A ;
GIARDIELLO, FM ;
FERRENBACH, S ;
DUBOIS, RN .
GASTROENTEROLOGY, 1994, 107 (04) :1183-1188